230 related articles for article (PubMed ID: 22447855)
1. Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11β-hydroxysteroid dehydrogenase 1.
Molusky MM; Li S; Ma D; Yu L; Lin JD
Diabetes; 2012 May; 61(5):1025-35. PubMed ID: 22447855
[TBL] [Abstract][Full Text] [Related]
2. Peroxisomal localization and circadian regulation of ubiquitin-specific protease 2.
Molusky MM; Ma D; Buelow K; Yin L; Lin JD
PLoS One; 2012; 7(11):e47970. PubMed ID: 23133608
[TBL] [Abstract][Full Text] [Related]
3. Direct regulation of glucose and not insulin on hepatic hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase type 1.
Fan Z; Du H; Zhang M; Meng Z; Chen L; Liu Y
Mol Cell Endocrinol; 2011 Feb; 333(1):62-9. PubMed ID: 21163329
[TBL] [Abstract][Full Text] [Related]
4. A sweet new role for ubiquitin-specific protease 2 in controlling hepatic gluconeogenesis.
Finck BN
Diabetes; 2012 May; 61(5):993-4. PubMed ID: 22517656
[No Abstract] [Full Text] [Related]
5. CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis.
Sakai M; Matsumoto M; Tujimura T; Yongheng C; Noguchi T; Inagaki K; Inoue H; Hosooka T; Takazawa K; Kido Y; Yasuda K; Hiramatsu R; Matsuki Y; Kasuga M
Nat Med; 2012 Mar; 18(4):612-7. PubMed ID: 22426420
[TBL] [Abstract][Full Text] [Related]
6. The KLF14 transcription factor regulates hepatic gluconeogenesis in mice.
Wang L; Tong X; Gu F; Zhang L; Chen W; Cheng X; Xie L; Chang Y; Zhang H
J Biol Chem; 2017 Dec; 292(52):21631-21642. PubMed ID: 29123026
[TBL] [Abstract][Full Text] [Related]
7. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
Liu Y; Nakagawa Y; Wang Y; Liu L; Du H; Wang W; Ren X; Lutfy K; Friedman TC
J Mol Endocrinol; 2008 Aug; 41(2):53-64. PubMed ID: 18524870
[TBL] [Abstract][Full Text] [Related]
8. Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet.
Li G; Hernandez-Ono A; Crooke RM; Graham MJ; Ginsberg HN
Metabolism; 2012 Jun; 61(6):823-35. PubMed ID: 22209663
[TBL] [Abstract][Full Text] [Related]
9. Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice.
Du H; Liu L; Wang Y; Nakagawa Y; Lyzlov A; Lutfy K; Friedman TC; Peng X; Liu Y
J Mol Endocrinol; 2013 Apr; 50(2):167-78. PubMed ID: 23267038
[TBL] [Abstract][Full Text] [Related]
10. Maternal protein restriction leads to enhanced hepatic gluconeogenic gene expression in adult male rat offspring due to impaired expression of the liver X receptor.
Vo TX; Revesz A; Sohi G; Ma N; Hardy DB
J Endocrinol; 2013 Jul; 218(1):85-97. PubMed ID: 23633563
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of hepatic 11β-hydroxysteroid dehydrogenase-1 expression in calcium-deficient rats.
Takaya J; Iharada A; Okihana H; Kaneko K
Ann Nutr Metab; 2011; 59(2-4):73-8. PubMed ID: 22142627
[TBL] [Abstract][Full Text] [Related]
12. Effects of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis.
Winnick JJ; Ramnanan CJ; Saraswathi V; Roop J; Scott M; Jacobson P; Jung P; Basu R; Cherrington AD; Edgerton DS
Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E747-56. PubMed ID: 23403942
[TBL] [Abstract][Full Text] [Related]
13. CREBH Maintains Circadian Glucose Homeostasis by Regulating Hepatic Glycogenolysis and Gluconeogenesis.
Kim H; Zheng Z; Walker PD; Kapatos G; Zhang K
Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28461393
[TBL] [Abstract][Full Text] [Related]
14. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
[TBL] [Abstract][Full Text] [Related]
15. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice.
Yuan X; Li H; Bai H; Zhao X; Zhang C; Liu H; Zhang Y; Zhao B; Wu Y; Liu J; Xiang Q; Feng B; Chu Y; Huang Y
Eur J Pharmacol; 2016 Oct; 788():140-151. PubMed ID: 27242185
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
[TBL] [Abstract][Full Text] [Related]
17. Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism.
Li G; Hernandez-Ono A; Crooke RM; Graham MJ; Ginsberg HN
J Lipid Res; 2011 May; 52(5):971-81. PubMed ID: 21364201
[TBL] [Abstract][Full Text] [Related]
18. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
[TBL] [Abstract][Full Text] [Related]
19. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
[TBL] [Abstract][Full Text] [Related]
20. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
